Co-Diagnostics IncNASDAQ:CODX
- LAST PRICE1.2700
- TODAY'S CHANGE (%)-0.0200 (-1.5504%)
- Bid / Lots1.2500/ 2
- Ask / Lots1.3000/ 10
- Open / Previous Close1.2700 / 1.2900
- Day Range
- 52 Week Range
- Volume15,844
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CODX |
|---|---|---|
| 09:32 ET | 594 | 1.27 |
| 09:48 ET | 680 | 1.27 |
| 09:57 ET | 2009 | 1.26 |
| 09:59 ET | 975 | 1.25 |
| 10:01 ET | 1900 | 1.25 |
| 10:06 ET | 1255 | 1.2497 |
| 10:08 ET | 1760 | 1.25 |
| 10:10 ET | 293 | 1.27 |
| 10:12 ET | 2112 | 1.27 |
Sep 5, 2024
Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test, from 9:30AM ET on Thursday Sep 05, 2024 by Dow Jones
9:30AM ET on Thursday Sep 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Co-Diagnostics Inc | 41.2M | -1.0x | --- |
T2 Biosystems Inc | 38.3M | -0.2x | --- |
Icecure Medical Ltd | 31.7M | -2.2x | --- |
Neuroone Medical Technologies Corp | 28.4M | -1.9x | --- |
Accelerate Diagnostics Inc | 36.5M | -0.7x | --- |
Medite Cancer Diagnostics Inc | 8.7K | 0.0x | --- |
Company Information
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
Contact Information
- Headquarters
- 4049 S Highland DrSALT LAKE CITY, UT, United States 84124-1664
- Phone
- 801-278-9769
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Dwight Egan
- President
- Richard Abbott
- Chief Financial Officer, Company Secretary
- Brian Brown
- Chief Operations Officer
- David Nielsen
- Chief Technology Officer
- Christopher Thurston
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $41.2M |
|---|---|
Revenue (TTM) | $9.1M |
Shares Outstanding | 31.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.86 |
EPS | $-1.27 |
Book Value | $2.75 |
P/E Ratio | -1.0x |
Price/Sales (TTM) | 4.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -424.64% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
